Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease
一项 II 期、开放标签、非对照临床试验,旨在评估泊沙康唑治疗已确诊/疑似侵袭性曲霉病或可能侵袭性真菌病的儿科患者的安全性和有效性。
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.01305-25
Kang, Hyoung Jin; Arrieta, Antonio C; Dhooge, Catharina; Kelemen, Ágnes; Macías-Parra, Mercedes; Aranda, Lourdes; Dinikina, Yulia V; Kassis, Imad; Cesaro, Simone; Shepherd, Aimee; Shah, Arvind K; Mackey, Tiffany; Waskin, Hetty; Johnson, Matthew G